ConductScience.org, home

Paper36976378

JAK/STAT signaling and cellular iron metabolism in hepatocellular carcinoma: therapeutic implications.

Rah B and 3 others. Clin Exp Med, 2023. Cited by 28 papers, by iCite.

Cite this record

ConductScience Library. JAK/STAT signaling and cellular iron metabolism in hepatocellular carcinoma: therapeutic implications. Papers, record 36976378. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36976378

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
JAK/STAT signaling and cellular iron metabolism in hepatocellular carcinoma: therapeutic implications.
PubMed
Journal
Clin Exp Med
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
28
iCite
Relative citation ratio, by iCite
3.12
iCite
Revised in PubMed
2026-10-31
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rah BBilal
2Farhat NMNada Mazen
3Hamad MMawieh
4Muhammad JSJibran Sualeh

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, HepatocellularMajor topic
Liver NeoplasmsMajor topic
Iron OverloadMajor topic
Humans
Signal Transduction
Janus Kinases
Iron
STAT Transcription Factors

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
22010901118Research Institute of Medical & Health Sciences, University of SharjahPubMed
2022-KHA-001King Hussein Cancer Foundation, JordanPubMed

Source PubMed

Download CSV of grants

References98

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132273976JAK/STAT signaling in hepatocellular carcinoma.Hepat Oncol2020https://conductscience.org/library/papers/32273976PubMed
232956413Adenomatous polyposis coli-binding protein end-binding 1 promotes hepatocellular carcinoma growth and metastasis.PLoS One2020https://conductscience.org/library/papers/32956413PubMed
326725301Regulators of Iron Homeostasis: New Players in Metabolism, Cell Death, and Disease.Trends Biochem Sci2016https://conductscience.org/library/papers/26725301PubMed
433925597On Iron Metabolism and Its Regulation.Int J Mol Sci2021https://conductscience.org/library/papers/33925597PubMed
529522138Pacritinib vs Best Available Therapy, Including Ruxolitinib, in Patients With Myelofibrosis: A Randomized Clinical Trial.JAMA Oncol2018https://conductscience.org/library/papers/29522138PubMed
620347012Nuclear ferritin: A new role for ferritin in cell biology.Biochim Biophys Acta2010https://conductscience.org/library/papers/20347012PubMed
725676869Phase 1 and pharmacological trial of OPB-31121, a signal transducer and activator of transcription-3 inhibitor, in patients with advanced hepatocellular carcinoma.Hepatol Res2015https://conductscience.org/library/papers/25676869PubMed
833895185Effect of hepcidin antagonists on anemia during inflammatory disorders.Pharmacol Ther2021https://conductscience.org/library/papers/33895185PubMed
929167669Iron Induces Anti-tumor Activity in Tumor-Associated Macrophages.Front Immunol2017https://conductscience.org/library/papers/29167669PubMed
1030578415Therapeutically exploiting STAT3 activity in cancer - using tissue repair as a road map.Nat Rev Cancer2019https://conductscience.org/library/papers/30578415PubMed
1134821176The mechanisms and therapeutic targets of ferroptosis in cancer.Expert Opin Ther Targets2021https://conductscience.org/library/papers/34821176PubMed
1230061739Molecular therapies and precision medicine for hepatocellular carcinoma.Nat Rev Clin Oncol2018https://conductscience.org/library/papers/30061739PubMed
1334373750Targeting iron metabolism in cancer therapy.Theranostics2021https://conductscience.org/library/papers/34373750PubMed
1431936571Ferroptosis in Cancer Cell Biology.Cancers (Basel)2020https://conductscience.org/library/papers/31936571PubMed
1532476555Estrogen-induced epigenetic silencing of FTH1 and TFRC genes reduces liver cancer cell growth and survival.Epigenetics2020https://conductscience.org/library/papers/32476555PubMed
1635806270Iron, Neuroinflammation and Neurodegeneration.Int J Mol Sci2022https://conductscience.org/library/papers/35806270PubMed
1732067993Ferroptosis, a novel pharmacological mechanism of anti-cancer drugs.Cancer Lett2020https://conductscience.org/library/papers/32067993PubMed
1834755647Iron disorders and hepcidin.Clin Chim Acta2021https://conductscience.org/library/papers/34755647PubMed
1931173262Sulfasalazine‑induced ferroptosis in breast cancer cells is reduced by the inhibitory effect of estrogen receptor on the transferrin receptor.Oncol Rep2019https://conductscience.org/library/papers/31173262PubMed
2030130469Iron and Cancer.Annu Rev Nutr2018https://conductscience.org/library/papers/30130469PubMed

See all 98 referencesDownload CSV of references

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.

PMIDTitleJournalYearIn PapersSource
42364008Exosomal LINC00323 accelerates angiogenesis through activating the MAPK and JAK-STAT pathways by stabilizing CDC5L in NSCLC.Cell Oncol (Dordr)2026https://conductscience.org/library/papers/42364008PubMed
42082970Nanocarrier-mediated targeting of NF-κB and JAK/STAT signaling pathways in hepatocellular carcinoma: mechanisms and therapeutic strategies.J Exp Clin Cancer Res2026https://conductscience.org/library/papers/42082970PubMed
42060013Unveiling the Intricate Dance: Signaling Pathways in Liver Cancer Metabolism and Immunity.Curr Oncol Rep2026https://conductscience.org/library/papers/42060013PubMed
41987273JAK/STAT signaling in liver disease: a therapeutic target or a context-dependent double-edged sword?J Transl Med2026https://conductscience.org/library/papers/41987273PubMed
41655180"Cytokine-Mediated tumor sensitization: mechanistic frameworks and therapeutic opportunities in cancer Immunotherapy".Clin Exp Med2026https://conductscience.org/library/papers/41655180PubMed
41452426Therapeutic potential of natural triterpenoids in liver cancer.Med Oncol2025https://conductscience.org/library/papers/41452426PubMed
41296440APOC2 Promotes Clear Cell Renal Cell Carcinoma Progression via Activation of the JAK-STAT Signaling Pathway.Curr Issues Mol Biol2025https://conductscience.org/library/papers/41296440PubMed
41140341Targeting ferroptosis as a therapeutic strategy for hepatotoxicity.Toxicol Rep2025https://conductscience.org/library/papers/41140341PubMed
41055645Modulation of hepcidin synthesis: the core link in the bi-directional relationship between iron and obesity.Rev Endocr Metab Disord2026https://conductscience.org/library/papers/41055645PubMed
40939292TIM-3 ameliorates host responses to Salmonella infection by controlling iron driven CD4+ T cell differentiation and interleukin-10 formation.EBioMedicine2025https://conductscience.org/library/papers/40939292PubMed
40822972Mechanism of triptolide regulating proliferation and apoptosis of hepatoma cells by inhibiting JAK/STAT pathway.Open Life Sci2025https://conductscience.org/library/papers/40822972PubMed
40420174Targeting inflammation in cancer therapy: from mechanistic insights to emerging therapeutic approaches.J Transl Med2025https://conductscience.org/library/papers/40420174PubMed
40298145Discovery and biological evaluation of a novel and highly potent JAK2 inhibitor for the treatment of triple negative breast cancer.J Enzyme Inhib Med Chem2025https://conductscience.org/library/papers/40298145PubMed
39881344Formin protein DAAM1 positively regulates PD-L1 expression via mediating the JAK1/STAT1 axis in pancreatic cancer.Cancer Cell Int2025https://conductscience.org/library/papers/39881344PubMed
39845897Butyrolactone I blocks the transition of acute kidney injury to chronic kidney disease in mice by targeting JAK1.MedComm (2020)2025https://conductscience.org/library/papers/39845897PubMed
39093298Iron Chelator Deferiprone Restores Iron Homeostasis and Inhibits Retinal Neovascularization in Experimental Neovascular Age-Related Macular Degeneration.Invest Ophthalmol Vis Sci2024https://conductscience.org/library/papers/39093298PubMed
38625672Liver cancer wars: plant-derived polyphenols strike back.Med Oncol2024https://conductscience.org/library/papers/38625672PubMed
38602575Integrating iron metabolism-related gene signature to evaluate prognosis and immune infiltration in nasopharyngeal carcinoma.Discov Oncol2024https://conductscience.org/library/papers/38602575PubMed
38519710Mechanisms and therapeutic prospect of the JAK-STAT signaling pathway in liver cancer.Mol Cell Biochem2025https://conductscience.org/library/papers/38519710PubMed
38375529Prognostic iron-metabolism signature robustly stratifies single-cell characteristics of hepatocellular carcinoma.Comput Struct Biotechnol J2024https://conductscience.org/library/papers/38375529PubMed

See all 21 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
HAMP57817PubTator's text mininghttps://conductscience.org/library/genes/57817

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36976378

GET https://conductscience.org/api/papers/v1/36976378/references?page=2